NovelBeam Technology(SH:688677) Xin Lang Cai Jing·2025-09-03 07:58Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is focused on integrating optical technology with cutting-edge medical device applications, particularly in high-performance endoscope products, and has been recognized as a "specialized, refined, distinctive, and innovative" enterprise, benefiting from the depreciation of the RMB [2][3]. Group 1: Company Overview - The company was established on June 11, 2003, and went public on February 26, 2021, specializing in the research, development, production, and sales of medical endoscope devices and optical products [7]. - The revenue composition of the company includes 64.86% from medical endoscope devices, 21.63% from optical products, 13.09% from maintenance services, and 0.42% from leasing [7]. - As of June 30, the company had 5,285 shareholders, an increase of 18.87%, with an average of 22,682 circulating shares per person, a decrease of 16.39% [7]. Group 2: Financial Performance - For the first half of 2025, the company achieved a revenue of 266 million yuan, representing a year-on-year growth of 20.50%, and a net profit attributable to the parent company of 74.44 million yuan, up 5.52% year-on-year [7]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8]. Group 3: Market Position and Trends - The company is one of the few in China with vertical integration capabilities from core components to system integration in the medical device industry [2]. - The company has a significant overseas revenue share of 69.12%, benefiting from the depreciation of the RMB [3]. - The stock has seen a recent trading volume of 76.51 million yuan with a market capitalization of 5.139 billion yuan [1].